Brainxell, INC:1270448 [18-001580]. Human cortical glutamatergic neurons.
Ended Purchase Order Awarded
- Contract number
- HHSN271201800176P
- Awardee
-
Brainxell, Inc. UEI CFGFE23M73T7
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $100,000
Award facts
- Opportunity
-
- NIHDA201800049 Solicitation number
- Human Cortical Glutamatergic Neurons Award Notice · Posted Feb 16, 2018
- Human Cortical Glutamatergic Neurons Award Notice · Posted Feb 1, 2018
- Contract value 100% obligated
- $100,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Madison, WI 53719, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
About this award
The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, awarded a $100,000.00 firm fixed-price purchase order contract to Brainxell, Inc., a for-profit manufacturer of human neuron cells. The contract is for the provision of human cortical glutamatergic neurons to support research on neurological disease and SARS-CoV-2 infectivity. Brainxell, as a prime contractor, has previously received grant awards from various National Institutes of Health (NIH) components to accelerate the development of human astrocytes and microglia derived from induced pluripotent stem cells for central nervous system drug screening. This contract award does not have a set-aside designation.
Quick answers
Who was awarded contract HHSN271201800176P?
HHSN271201800176P was awarded to Brainxell, Inc. by National Institute on Drug Abuse (National Institutes of Health) on March 9, 2018.
How much is contract HHSN271201800176P worth?
The government has obligated $100,000 on HHSN271201800176P.
Which agency awarded contract HHSN271201800176P?
National Institute on Drug Abuse (National Institutes of Health) awarded HHSN271201800176P, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract HHSN271201800176P competed?
The extent of competition for HHSN271201800176P was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award